LY2510924

LY2510924 is a potent and selective CXCR4 antagonist that specifically blocks SDF-1 binding to CXCR4 with IC50 value of 0.079 nmol/L and inhibits SDF-1-induced GTP binding with Kb value of 0.38 nmol/L.

LY2510924 Chemical Structure

LY2510924 Chemical Structure

CAS: 1088715-84-7

Selleck's LY2510924 has been cited by 1 publication

Purity & Quality Control

Batch: Purity: 99.84%
99.84

LY2510924 Related Products

Signaling Pathway

Choose Selective CXCR Inhibitors

Biological Activity

Description LY2510924 is a potent and selective CXCR4 antagonist that specifically blocks SDF-1 binding to CXCR4 with IC50 value of 0.079 nmol/L and inhibits SDF-1-induced GTP binding with Kb value of 0.38 nmol/L.
Targets
CXCR4 [1]
(Cell-free)
0.079 nM
In vitro
In vitro In human lymphoma U937 cells expressing endogenous CXCR4, LY2510924 inhibits SDF-1-induced cell migration with IC50 value of 0.26 nmol/L and inhibits SDF-1/CXCR4-mediated intracellular signaling. LY2510924 exhibits a concentration-dependent inhibition of SDF-1-stimulated phospho-ERK and phospho-Akt in tumor cells. Biochemical and cellular analyses reveal that LY2510924 has no apparent agonist activity. LY2510924 has no inhibitory activities against other chemokine receptors including CCR1, CCR2, CXCR2, and CXCR3 at the concentrations tested. Similarly, there is no activity observed among serotonin, dopamine, and opioid receptors[1].
Cell Research Cell lines U937 cells
Concentrations --
Incubation Time 2.5 h
Method

U937 cells are harvested and washed once with chemotaxis assay buffer prepared with 1× RPMI medium containing 10 mmol/L HEPES, pH 7.5, and 0.3% BSA. Cells are then resuspended in assay buffer at a density of 5 × 106 cells/mL. The assay is performed in a 96-well ChemoTx plate. Generally, 50 μL of cell mixture with or without LY2510924 was plated on the upper chamber, and 30 μL of SDF-1α (10 ng/mL) prepared in 1× chemotaxis buffer was added to the lower chamber. The plate is then incubated for 2.5 hours at 37°C. Following the incubation, 5 μL of CellTiter 96 AQ is added into the lower chamber. The plate is then incubated for 60 minutes at 37°C. The migrated cells are detected by measuring the absorbance at 492 nm.

In Vivo
In vivo LY2510924 has acceptable in vivo stability and a pharmacokinetic profile similar to a typical small-molecular inhibitor in preclinical species. LY2510924 shows dose-dependent inhibition of tumor growth in human xenograft models developed with non-Hodgkin lymphoma, renal cell carcinoma, lung, and colon cancer cells that express functional CXCR4. In MDA-MB-231, a breast cancer metastatic model, LY2510924 inhibits tumor metastasis by blocking migration/homing process of tumor cells to the lung and by inhibiting cell proliferation after tumor cell homing. LY2510924 has a dramatically improved in vivo stability with a half-life of 3 to 5 hours in preclinical species and 9.16 hours in humans at the recommended phase II dose[1].
Animal Research Animal Models female C57/BL6 mice, male Sprague–Dawley rats, male Beagle dogs, and male Cynomolgus monkeys at fasted state
Dosages 3 mg/kg
Administration subcutaneous (s.c.) or intravenous (i.v.) injection
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT02737072 Terminated
Solid Tumor
Eli Lilly and Company|AstraZeneca
September 2016 Phase 1
NCT02652871 Completed
Leukemia
M.D. Anderson Cancer Center|Eli Lilly and Company|High Impact Clinical Research Support Program
May 9 2016 Phase 1

Chemical Information & Solubility

Molecular Weight 1189.45 Formula

C62H88N14O10

CAS No. 1088715-84-7 SDF Download LY2510924 SDF
Smiles CC(C)NCCCCC1C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(CCC(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)CC3=CC=CC=C3)C(=O)NC(CCCCNC(C)C)C(=O)N)CC4=CC5=CC=CC=C5C=C4)CCCN=C(N)N
Storage (From the date of receipt)

In vitro
Batch:

Water : 100 mg/mL


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy LY2510924 | LY2510924 supplier | purchase LY2510924 | LY2510924 cost | LY2510924 manufacturer | order LY2510924 | LY2510924 distributor